Bal Pharma fundamental analysis

BALPHARMA

70.7

1.74 (-2.40%)
Last updated on 12 Jan, 2026 | 11:20 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Bal Pharma Fundamentals

P/E Ratio

16.97

P/B Ratio

1.48

Div. Yield

1.65

Sector P/E

69.98

Sector P/B

0.94

Sec. Div. Yield

0.57

Bal Pharma Fundamentals is currently trading with a P/E Ratio of 16.97, compared to the sector average of 69.98. Its P/B Ratio stands at 1.48, while the sector’s is 0.94. In terms of returns, the stock offers a Dividend Yield of 1.65%, which is than the sector’s 0.57%.

Bal Pharma Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Bal Pharma reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.